on RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
Lantern Pharma's Innovative AI Approach Featured on Bloomberg TV
An insightful interview featuring Lantern Pharma Inc.'s CEO, Panna Sharma, will be aired on Bloomberg TV's RedChip Small Stocks, Big Money™ show. Scheduled for July 26 at 7 p.m. ET, this event highlights Lantern's groundbreaking use of AI in oncology drug development.
Lantern Pharma leverages its proprietary RADR® platform to redefine cancer treatment. The company focuses on clinical-stage programs like LP-300, LP-184, and LP-284, addressing critical needs in oncology. The AI-driven model enables high efficiency and cost-effectiveness, propelling rapid advancements.
Sharma emphasizes Lantern’s expansion, showcasing numerous upcoming clinical readouts and a growing pipeline. With over 100 patents in its arsenal, Lantern aims to solidify its standing as a leader at the confluence of AI and precision oncology.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all RedChip Companies, Inc. (Media Suite) news